PBM has the potential to treat many pathologies that arise from AD including Aβ load, intracellular tau tangles, neuroinflammation, oxidative stress, decreased trophic factor expression, and metabolic dysfunction. The gene discussed is MAPT; the disease is Alzheimer disease.